Tenax Therapeutics Inc (TENX): Levosimendin demonstrated statistically...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	339
Posts	19333
Boards Moderated	0
Alias Born	08/25/2007

zino

Re: zino post# 7554

Wednesday, 09/13/2017 11:21:56 AM

Wednesday, September 13, 2017 11:21:56 AM

Levosimendin demonstrated statistically significant reductions in two of three secondary endpoints including:
Reduction in low cardiac output syndrome (LCOS)
Reduction in postoperative use of secondary inotropes.

DONT LISTEN TO ME IM CANADIANNNNNNNN

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent TENX News

Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/13/2024 04:15:07 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/12/2024 08:15:28 PM
Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/10/2024 09:19:47 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/30/2024 08:20:02 PM
Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/19/2024 10:48:03 PM
Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/19/2024 08:15:15 PM
Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/15/2024 08:19:12 PM
Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/14/2024 10:47:35 PM
Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/14/2024 07:19:24 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:45:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:30:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 12:35:42 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 11:43:25 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 11:42:23 PM
Biotech Soars Following Oversubscribed $100M Private Placement Announcement • AllPennyStocks.com • 08/06/2024 08:55:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 11:23:52 AM
Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:32:09 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 09:01:41 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 09:00:50 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:01:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 01:01:43 PM
Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update • GlobeNewswire Inc. • 05/14/2024 12:00:00 PM

More TENX News

InvestorsHub NewsWire

VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM

Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM

HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM

Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM

Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM

PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover